Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Scientific Title
A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR or HER2 Mutation